These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation. Belavic JM Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210 [No Abstract] [Full Text] [Related]
5. Edoxaban: a review in nonvalvular atrial fibrillation. McCormack PL Am J Cardiovasc Drugs; 2015 Oct; 15(5):351-61. PubMed ID: 26369340 [TBL] [Abstract][Full Text] [Related]
6. Quality of anticoagulation control in atrial fibrillation. Lane DA; Lip GY Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499 [No Abstract] [Full Text] [Related]
7. Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation? Plitt A; Giugliano RP Future Cardiol; 2014 Mar; 10(2):153-5. PubMed ID: 24762238 [No Abstract] [Full Text] [Related]
11. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48. Giugliano RP; Ruff CT; Rost NS; Silverman S; Wiviott SD; Lowe C; Deenadayalu N; Murphy SA; Grip LT; Betcher JM; Duggal A; Dave J; Shi M; Mercuri M; Antman EM; Braunwald E; Stroke; 2014 Aug; 45(8):2372-8. PubMed ID: 24947287 [TBL] [Abstract][Full Text] [Related]
12. Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke. Yoon CH; Park YK; Kim SJ; Lee MJ; Ryoo S; Kim GM; Chung CS; Lee KH; Kim JS; Bang OY Stroke; 2014 Oct; 45(10):2983-8. PubMed ID: 25147329 [TBL] [Abstract][Full Text] [Related]
13. At last, a RE-LYable alternative to warfarin for atrial fibrillation. Hankey GJ Int J Stroke; 2009 Dec; 4(6):454-5. PubMed ID: 19930055 [No Abstract] [Full Text] [Related]
16. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary. Waks JW; Zimetbaum PJ Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1461-71. PubMed ID: 24147516 [TBL] [Abstract][Full Text] [Related]
17. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation? Strain J; Templeton K S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716 [No Abstract] [Full Text] [Related]
18. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
19. Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"? Halperin JL; Goyette RE Mt Sinai J Med; 2012; 79(6):705-20. PubMed ID: 23239209 [TBL] [Abstract][Full Text] [Related]
20. [Stroke prevention in atrial fibrillation. Marcumar alternative in sight]. Einecke D MMW Fortschr Med; 2009 Sep; 151(38):12-4. PubMed ID: 19831172 [No Abstract] [Full Text] [Related] [Next] [New Search]